Skip to content

Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients

Comparing efficacy of ECT with and without concurrent sodium valproate therapy in manic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901161743N3
Enrollment
42
Registered
2010-04-20
Start date
2010-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Manic episode of bipolar disorder. Bipolar affective disorder, current episode manic without psychotic symptoms, Bipolar affective disorder, current episode manic with psychotic symptoms

Interventions

Intervention 1: discontinuation of sudium valproate. Intervention 2: continuation of sudium valproate.
Treatment - Drugs
discontinuation of sudium valproate
continuation of sudium valproate

Sponsors

Research center for behavioral disorders and substance abuse, Hamadan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: obtaining informed consent, Diagnosis of bipolar I disorder, manic episode, must be confirmed according to DSM IV-TR criteria, Manic episode refractory to pharmacotherapy, receiving therapeutic doses of valproate before ECT for at least 5 days, Serum levels of valproate =50 µg/ml, Administration of ECT by attending psychiatrist, age 18-60 years Exclusion criteria: Uncontrolled physical condition, Pregnant and nursing women, LFT: 3 fold greater than upper normal limits, receiving other anticonvulsant medications, History of epilepsy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement rate of mania. Timepoint: after second, fourth, sixth and at the end of sessions of ECT. Method of measurement: CGI and YMRS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Bigdelo

Research center for behavioral disorders and substance abuse, Hamadan university of medical sciences

rbigdelo@yahoo.com+98 81 1828 5015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026